2nd Hippo Pathway Targeted Drug Development Summit

Conference themes
It has been long understood that the Hippo pathway has clear therapeutic potential in the treatment of cancer resistance, tissue repair, and cardiac regeneration. Now, this highly attractive and targetable pathway is experiencing investment, collaboration, and interest from biopharma and academia; a once unexploited pathway is now on the brink of its first positive phase 1 clinical readout.

Professional congress organizer (PCO)
Hanson Wade

Notes
URLs:
Tickets: https://go.evvnt.com/1521706-2?pid=4832
Brochure: https://go.evvnt.com/1521706-3?pid=4832

Speakers: Adeela Kamal Senior, Vice President Research and Development, SpringWorks Therapeutics, and more.

https://go.evvnt.com/1521706-2?pid=4832

Ms. Isabella Hunter